Investing in healthcare stocks has its perks. Since medical services are always in high demand, investors can rest assured that the industry won't stop being relevant anytime soon.

Still, things evolve quickly in healthcare, so it's important to find stocks that can stay ahead of the curve or, at the very least, keep up with the changing nature of the sector. Plenty of corporations on the market can do so, one of which is CRISPR Therapeutics (NASDAQ: CRSP). Let's find out why this gene-editing expert is worth investing in for the long haul.

Gene editing is a set of techniques that allows scientists to make precise changes to an organism's DNA. If a defective gene causes a disease, editing the gene in question might be a solution to treating or even curing the illness. CRISPR Therapeutics' entire platform is based on this simple-sounding idea that is extremely complicated to pull off in practice. The approach is relatively novel, too.

Continue reading

Source Fool.com